Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

In vitro evaluation of phosphate, bicarbonate, and hepes buffered storage solutions on hypothermic injury to immature myocytes

Summary

In this study we evaluated cardiac myocyte viability and function under hypothermic conditions using three types of buffer solutions: phosphate buffer solution (PBS), Krebs-Henseleit bicarbonate buffer solution (KHB), and Hepes buffered minimum salt solution (MSS). As a control, normal saline solution (NSS) was used. Cardiac myocytes were isolated from neonatal rat ventricles. Myocytes (12.5 × 105 myocytes/culture flask) were then incubated at 4°C for 6, 12, 18, and 24 hours in various buffer solutions. After each incubation time, CPK and LDH were measured. The myocytes were then incubated for an additional 24 hours at 37°C to evaluate the recovery of the myocyte beating rate. Group MSS had a significantly better beating rate recovery than group NSS (control) after 18 hours (MSS, 32.7%, NSS, 0.0% of control; i.e., beating rate prior to hypothermic incubation). In contrast, group KHB showed a significantly lower recovery ratio than group NSS at 12 hours (41.0%, 78.8%, respectively), and the lowest recovery was observed in group PBS beginning at 6 hours of hypothermic incubation (27.6%). Group MSS significantly suppressed the release of CPK and LDH compared to group NSS at 24 hours (MSS, 246.7 and 440.2 mIU/flask; NSS, 369.7 and 821.3 mIU/flask, respectively). In contrast, groups PBS and KHB showed significantly increased CPK and LDH levels compared to group NSS after 12 hours (PBS, 388.6 and 721.4 mIU/flask; KHB, 340.5 and 540.5 mIU/flask; NSS, 91.5 and 222.7 mIU/flask, respectively). In conclusion, Hepes buffer has cytoprotective characteristics that may be suitable for long-term hypothermic preservation of immature myocardium compared to phosphate or bicarbonate buffer.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Burt JM, Copeland JG. Myocardial function after preservation for 24 hours.J Thorac Cardiovasc Surg 1986;92:238–246.

  2. 2.

    Takahashi A, Braimbridge MV, Hearse DJ, Chambers DJ. Long-term preservation of the mammalian myocardium. Effect of storage medium and temperature on the vulnerability to tissue injury.J Thorac Cardiovasc Surg 1991;102:235–244.

  3. 3.

    Wicomb W, Cooper DKC, Hassoulas J, Rose AG, Barnard CN. Orthotopic transplantation of the baboon heart after 20 to 24 hours' preservation by continuous hypothermic perfusion with an oxygenated hyperosmolar solution.J Thorac Cardiovasc Surg 1982;83:133–140.

  4. 4.

    Warner M, Guerraty A, Alivizatos P, et al. Assessment of myocardial subcellular function after 24 hours of in vitro preservation and transplantation.J Thorac Cardiovasc Surg 1982;83:290–297.

  5. 5.

    Jarmakani JM, Nakazawa M, Nagatomo T, Langer GA. Effect of hypoxia on mechanical function in the neonatal mammalian heart.Am J Physiol 1978;235:H469-H474.

  6. 6.

    Bove EL, Gallagher KP, Drake DH, et al. The effect of hypothermic ischemia on recovery of left ventricular function and preload reserve in the neonatal heart.J Thorac Cardiovasc Surg 1988;95:814–818.

  7. 7.

    Grice WN, Konishi T, Apstein CS. Resistance of neonatal myocardium to injury during normothermic and hypothermic ischemic arrest and reperfusion.Circulation 1987;76(Suppl V):V150-V155.

  8. 8.

    Orita H, Fukasawa M, Hirooka S, Fukui K, Kohi M, Washio M. A cardiac myocyte culture system as an in vitro experimental model for the evaluation of hypothermic preservation.Surgery Today 1993;23:439–443.

  9. 9.

    Orita H, Fukasawa M, Hirooka S, Fukui K, Kohi M, Washio M. Protection of cardiac myocytes from hypothermic injury by cardiac fibroblasts isolated from neonatal rat ventricle.J Surg Res 1993;55:654–658.

  10. 10.

    Orita H, Fukasawa M, Hirooka S, et al. Modulation of cardiac myocyte beating rate and hypertrophy by cardiac fibroblasts isolated from neonatal rat ventricle.Jpn Circ J 1993;57:912–920.

  11. 11.

    Klein I, Daood M. Regulation of the growth of nonmuscle heart cells in culture.In Vitro Cell Dev Biol 1985;21:693–696.

  12. 12.

    Suzuki T, Ohta M, Hoshi H. Serum-free, chemically defined medium to evaluate the direct effects of growth factors and inhibitors on proliferation and function of neonatal rat cardiac muscle cells in culture.In Vitro Cell Dev Biol 1989;25:601–606.

  13. 13.

    Blondel B, Roijen I, Cheneval JP. Heart cells in culture: A simple method for increasing the population of myoblasts.Experiential 1971;27:356–358.

  14. 14.

    Polinger IS. Separation of cell types in embryonic heart cell culture.Exp Cell Res 1970;63:78–82.

  15. 15.

    Yagev S, Heller M, Pinson A. Change in cytoplasmic and lysosomal enzyme activities in cultured rat heart cells: The relationship to cell differentiation and cell population in culture.In Vitro Cell Dev Biol 1984;20:893–898.

  16. 16.

    Siegel S, Castellan NJ Jr. The Kruskal-Wallis one-way analysis of variance by ranks. In: Anker JD, ed.Nonparametric Statistics for the Behavioral Sciences. New York: McGraw-Hill, 1988:206–216.

  17. 17.

    Siegel S, Castellan NJ Jr. The Wilcoxon-Mann-Whitney test. In: Anker JD, ed.Nonparametric Statistics for the Behavioral Sciences. New York: McGraw-Hill, 1988:206–216.

  18. 18.

    Mavroudis C, Harrison H, Klein JB. Infant orthotopic cardiac transplantation.J Thorac Cardiovasc Surg 1988;96:912–924.

  19. 19.

    Pennington DG, Noedel N, McBride LR, Naunheim KS, Ring WS. Heart transplantation in children: An international survey.Ann Thorac Surg 1991;52:710–715.

  20. 20.

    Hendry PJ, Labow RS, Barry TA, Keon WJ. An assessment of crystalloid solutions for donor heart preservation.J Thorac Cardiovasc Surg 1991;101:833–838.

  21. 21.

    Fremes SE, Li RK, Weisel RD, Mickle DAG, Tumiati LC. Prolonged hypothermic cardiac storage with University of Wisconsin solution. An assessment with human cell culture.J Thorac Cardiovasc Surg 1991;102:666–672.

  22. 22.

    Orita H, Fukasawa M, Hirooka S, et al. Cardiac myocyte functional and biochemical changes after hypothermic preservation in vitro: Protective effects of storage solutions.J Thorac Cardiovasc Surg 1994;107:226–232.

  23. 23.

    Goshima K: A study on the preservation of the beating rhythm of single myocardial cells in vitro.Exp Cell Res 1973;80:432–438.

  24. 24.

    Laarae AVD, Hollaar L, Kokshoorn LJM, Witteveen SAGJ. The activity of cardio-specific isoenzymes of creatine phosphokinase and lactate dehydrogenase in monolayer cultures of neonatal rat heart cells.J Mol Cell Cardiol 1979;11:501–510.

  25. 25.

    Acosta D, Puckett M, McMillin R. Ischemic myocardial injury in cultured heart cells: Leakage of cytoplasmic enzymes from injured cells.In Vitro Cell Dev Biol 1978;14:728–732.

  26. 26.

    Bers DM, Bridge JHB, Spizer KW. Intracellular Ca++ transients during rapid cooling contractures in guinea-pig ventricular myocytes.J Physiol 1989;417:537–553.

  27. 27.

    Hryshko LV, Stiffel V, Bers DM. Rapid cooling contractures as an index of sarcoplasmic reticulum calcium content in rabbit ventricular myocytes.Am J Physiol 1989;257:H1369–377.

  28. 28.

    Good NE, Winget GD, Winter W, Connolly TN, Izawa S, Singh RMM: Hydrogen ion buffers for biological research.Biochemistry 1966;5:467–477.

  29. 29.

    Collins GM, Bravo-Shugarman M, Terasaki PI. Kidney preservation for transplantation.Lancet 1969;2:1219–1222.

Download references

Author information

Correspondence to Hiroyuki Orita MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Orita, H., Fukasawa, M., Hirooka, S. et al. In vitro evaluation of phosphate, bicarbonate, and hepes buffered storage solutions on hypothermic injury to immature myocytes. Cardiovasc Drug Ther 8, 851–859 (1994). https://doi.org/10.1007/BF00877404

Download citation

Key Words

  • cardiac myocyte
  • hypothermic injury
  • phosphate buffer
  • bicarbonate buffer
  • Hepes buffer